High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer
This study is currently recruiting participants.
Verified July 2012 by The Netherlands Cancer Institute
Sponsor:
The Netherlands Cancer Institute
Information provided by (Responsible Party):
The Netherlands Cancer Institute
ClinicalTrials.gov Identifier:
NCT01646034
First received: June 14, 2012
Last updated: July 19, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2019 |
| Estimated Primary Completion Date: | July 2017 (Final data collection date for primary outcome measure) |